DERMATOLOGICALS IN EGYPT

Euromonitor International

February 2019

LIST OF CONTENTS AND TABLES

Headlines

Prospects

Low Confidence in Topical Products Hampers Demand in Dermatologicals

Nappy (diaper) Rash Treatments Registers Dynamic Performance Despite Price Hikes

Demand for Paediatric Dermatologicals Remains Very Low

Competitive Landscape

GlaxoSmithKline Leads Dermatologicals in 2018

Strict Price Controls Will Continue To Discourage Innovation

Category Data

Table 1 Sales of Dermatologicals by Category: Value 2013-2018

Table 2 Sales of Dermatologicals by Category: % Value Growth 2013-2018

Table 3 NBO Company Shares of Dermatologicals: % Value 2014-2018

Table 4 LBN Brand Shares of Dermatologicals: % Value 2015-2018

Table 5 LBN Brand Shares of Hair Loss Treatments: % Value 2015-2018

Table 6 Forecast Sales of Dermatologicals by Category: Value 2018-2023

Table 7 Forecast Sales of Dermatologicals by Category: % Value Growth 2018-2023

Executive Summary

Consumer Health Stabilises in 2018 Following Crisis of 2017

Price Hikes Impact Negatively on Volume Sales in Most Categories

Rigid Regulatory Environment Continues To Discourage New Entries

Chemists/pharmacies Continue To Dominate Consumer Health Distribution

Demand Expected To Remain Strong Despite Strict Regulatory Controls

Market Indicators

Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2013-2018

Table 9 Life Expectancy at Birth 2013-2018

Market Data

Table 10 Sales of Consumer Health by Category: Value 2013-2018

Table 11 Sales of Consumer Health by Category: % Value Growth 2013-2018

Table 12 NBO Company Shares of Consumer Health: % Value 2014-2018

Table 13 LBN Brand Shares of Consumer Health: % Value 2015-2018

Table 14 Distribution of Consumer Health by Format: % Value 2013-2018

Table 15 Distribution of Consumer Health by Format and Category: % Value 2018

Table 16 Forecast Sales of Consumer Health by Category: Value 2018-2023

Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2018-2023

Appendix

OTC Registration and Classification

Vitamins and Dietary Supplements Registration and Classification

Self-medication/self-care and Preventive Medicine

Switches

Sources

Summary 1 Research Sources

For a country with a population of close to 100 million, dermatologicals in Egypt remained a relatively small category in value terms in 2018. This reflected the widespread belief among Egyptians that products in cream format will not have an immediate and lasting effect on painful or uncomfortable skin conditions. If consumers do use dermatologicals products, it is usually in combination with systemic treatments, which are seen as providing faster and more effective relief from such conditions.

Euromonitor International's Dermatologicals in Egypt report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2014-2018, allowing you to identify the sectors driving growth. Forecasts to 2023 illustrate how the market is set to change.

Product coverage: Antiparasitics/Lice (Head and Body) Treatments, Antipruritics, Cold Sore Treatments, Haemorrhoid Treatments, Hair Loss Treatments, Medicated Shampoos, Nappy (Diaper) Rash Treatments, Paediatric Dermatologicals, Topical Allergy Remedies/Antihistamines, Topical Antifungals, Topical Germicidals/Antiseptics, Vaginal Antifungals.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the Dermatologicals market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.